Is WST Stock Undervalued At $200?
Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...
West Pharmaceutical forecasts 2025 results below expectations, shares drop
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
This Pharma Stock Is Today’s Worst in the S&P 500. Here’s Why.
West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...
West Pharmaceutical price target lowered to $325 from $470 at KeyBanc
KeyBanc analyst Paul Knight lowered the firm’s price target on West Pharmaceutical (WST) to $325 from $470 to reflect lower FY25 estimates and ...
West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...
West Pharma upgraded at Deutsche Bank despite earnings led selloff
Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...